Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Filings indexed 1,664 across all filing types
Latest filing 2021-04-26 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
ComASUR Key Milestone 2 pages 198.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 27 April 2021 from Anteris Technologies Ltd reporting a key milestone in the development of its ComASUR Transfemoral Delivery System and related animal studies. It discusses product development progress, FDA approval process steps, and technology innovation. There are no financial statements, no quarterly or annual financial results, no voting results, no management or board changes, no legal proceedings, no capital or financing updates, and no regulatory certifications. The document is a corporate announcement about a product development milestone rather than a financial or regulatory filing. It is relatively short (3833 characters) and does not contain detailed financial data or formal report content. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-04-26 English
Appendix 4C - quarterly 9 pages 328.8KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Activity Report for the Period to 31 March 2021' and includes detailed financial data such as cash flow statements, cash receipts, cash outflows, financing activities, and commentary on the quarter's activities. It references the Appendix 4C, which is a quarterly cash flow report required by the ASX Listing Rules. The document contains substantive financial data and analysis for a quarter, not just an announcement or summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2021
2021-04-21 English
Change in substantial holding 2 pages 220.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 under the Corporations Act 2001, titled 'Notice of change of interests of substantial holder.' It details changes in voting power and shareholdings of a substantial holder in the company Anteris Technologies Ltd. The form includes dates of changes, nature of changes, and relevant interests, which are typical of notifications about major shareholding changes. There is no financial performance data, management discussion, or audit information. The document is regulatory in nature, specifically notifying changes in significant share ownership levels, which aligns with the definition of Major Shareholding Notification (MRQ). The document length is 6556 characters, sufficient to contain detailed information but focused solely on shareholding changes.
2021-04-14 English
Annual Report to shareholders 104 pages 5.5MB
Regulatory Filings
2021-04-14 English
Appendix 4G and Corporate Governance Statement 22 pages 1.7MB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations' and references ASX Listing Rules 4.7.3 and 4.10.3. It is a governance-related disclosure document that serves as a key to where corporate governance disclosures can be found, and it accompanies the annual report but is not the annual report itself. The document includes detailed compliance with corporate governance principles and recommendations, with references to the corporate governance statement either in the annual report or on the company's website. It is not a full annual report, audit report, or financial statement, but rather a regulatory filing related to governance disclosures required by the ASX listing rules. The document is about governance disclosures and compliance, not about management changes, earnings, or capital updates. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a regulatory compliance document that does not fit into other specific categories like Annual Report or Governance Information (CGR) which typically would be the full governance report rather than this key to disclosures form.
2021-04-14 English
Appendix 2A 16 pages 315.6KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the securities to be quoted, and references to previous announcements such as Appendix 3B. The content is regulatory in nature, related to securities issuance and listing compliance, but it is not a financial report, earnings release, or management discussion. It is a formal regulatory announcement required by the exchange for securities quotation. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2021-04-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.